No results for ‘’
Camlin Fine Sciences Ltd
₹122.54
(1.10%)
Wed, 27 May 2026, 05:56 pm
Process Industries
Chemicals: Specialty
24.5KCamlin Fine Sciences Debt to Equity Ratio
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 7.54 | 43.69 | 8.60 | 27.66 | 4.83 | 6.29 | 15.36 | 23.85 | 0 | 0 | 1050 | 15.77 | 37.95 | 30.62 | 41.42 | 0 | 0 |
| Price to book ratio | 0 | 0 | 0.63 | 1.80 | 1.36 | 1.98 | 1.11 | 1.94 | 6.28 | 4.85 | 4.36 | 3.33 | 1.63 | 1.19 | 2.77 | 2.93 | 2.44 | 1.73 | 3.50 |
| Price to sales ratio | 0 | 0 | 0.18 | 0.38 | 0.36 | 0.31 | 0.19 | 0.36 | 1.52 | 1.77 | 1.72 | 1.57 | 0.68 | 0.46 | 1.64 | 1.32 | 1.28 | 1.04 | 1.75 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 1.90 | 48.87 | 36.27 | 17.57 | 0 | 0 | 0 | 9.66 | 27.45 | 15.26 | 0 | 22.37 | 0 |
| Enterprise value | 0 | 0 | 451.52M | 960.84M | 1.16B | 2.2B | 1.73B | 3.15B | 9.86B | 10.16B | 12.14B | 13.99B | 10.18B | 10.09B | 24.16B | 23.78B | 28.64B | 20.9B | 33.7B |
| Enterprise value to EBITDA ratio | 0 | 0 | 2.64 | 7.63 | 10.12 | 7.28 | 3.62 | 4.87 | 11.52 | 11.53 | 29.73 | 102.55 | 15.56 | 7.98 | 12.34 | 15.30 | 13.11 | 11.07 | 15.81 |
| Debt to equity ratio | 1.04 | 0.76 | 0.97 | 1.60 | 1.47 | 2.36 | 1.92 | 1.61 | 1.19 | 1.02 | 1.56 | 1 | 1.24 | 1.34 | 0.85 | 0.86 | 0.98 | 0.79 | 0.76 |
| Return on equity % | 0 | 10.92 | 8.59 | 4.16 | 18.81 | 7.63 | 25.52 | 36.19 | 48.23 | 23.03 | -6.57 | -11.60 | 0.16 | 7.83 | 9.74 | 8.72 | 6.65 | 7.73 | 7.75 |
Camlin Fine Sciences Ltd Debt to Equity Ratio
The Camlin Fine Sciences Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Camlin Fine Sciences Ltd's valuation, profitability, and overall financial performance. Tracking the Camlin Fine Sciences Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Camlin Fine Sciences Ltd (NSE: CAMLINFINE, BSE: 532834) is currently trading at ₹122.54, with a market capitalization of ₹23.31B. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Camlin Fine Sciences Ltd Debt to Equity Ratio is essential for fundamental analysis.
Camlin Fine Sciences Ltd Debt to Equity Ratio Current Value
The current Camlin Fine Sciences Ltd Debt to Equity Ratio stands at 0.76.
The Camlin Fine Sciences Ltd Debt to Equity Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Camlin Fine Sciences Ltd Debt to Equity Ratio Historical Trend
The Camlin Fine Sciences Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0.76
- 2023: 0.79
- 2022: 0.98
- 2021: 0.86
- 2020: 0.85
The decline in Camlin Fine Sciences Ltd Debt to Equity Ratio indicates improving financial efficiency or better earnings growth.
What Camlin Fine Sciences Ltd Debt to Equity Ratio Indicates for Investors
The Camlin Fine Sciences Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Camlin Fine Sciences Ltd Debt to Equity Ratio Analysis Summary
The Camlin Fine Sciences Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Camlin Fine Sciences Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Camlin Fine Sciences Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.